甘璐 教授 职称职务:教授/博士生导师 纳米药物制剂研发部 学科专业:分子生物物理 E - mail: lugan@mail.hust.edu.cn 学习与工作经历: 1996获华中农业大学食品工程学士学位 2001获华中农业大学食品加工及储藏工程博士学位 2001.7-2003.6华中科技大学生物医学工程博士后流动站 博士后 2003.7-至今 华中科技大学生命科学与技术学院 2006.5-2007.9 美国圣路易斯华盛顿大学医学院 博士后 2007.10-2009.5 美国明尼苏达大学Masonic癌症中心 博士后 研究领域 (1)肿瘤信号转导 (2)纳米肿瘤学 承担课题 • NSFC:MEKK1-FOXO1信号通路在前列腺癌转移中的作用和机制研究 (2011-2013) • NSFC青年基金:活性氧调控胰岛素分泌的分子机制(2006-2008) • 国家重大科学研究计划:基于纳米技术的肝癌早期诊断的研究课题三:肝癌影像学早期诊断靶标纳米对比剂的生物特性及其成像技术 (2011-2015) • 湖北省科技攻关项目: 大蒜素纳米乳注射液的研制 (2007-2009) 论文与获奖情况 • 发表SCI论文20余篇,累计他引200余次 • 获湖北省科技进步二等奖1项 • 参编专著2部(《纳米药物》和《硒的化学、生物化学及其在生命科学中的应用》) 代表性论著 1. Zhen Zhang, Xiaoqin Xiong, Jiangling Wan, Ling Xiao, Lu Gan*, Youmei Feng, Huibi Xu, Xiangliang Yang*.Cellular uptake and intracellular trafficking of PEG-b-PLA polymeric micelles.Biomaterials, 2012, 33(29): 7233-7240. 2. Chun Zhang*, Ying Liu, Xiaoqin Xiong, Lianhui Peng, Lu Gan*, Chuanfeng Chen*, Huibi Xu. Three-dimensional nanographene based on triptycene: synthesis and its application in fluorescence imaging. Organic Letters, 2012, 14(23): 5912-5915. 3. Ling Xiao, Xiaoqin Xiong, Xiaohui Sun, Yanhong Zhu, Hao Yang, Huabing Chen, Lu Gan*, Huibi Xu, Xiangliang Yang*.Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials, 2011, 32(22) :5148-5157. 4. Lu Gan*, Jianling Wang, Huibi Xu, Xiangliang Yang. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling. Prostate, 2011, 71(11): 1158-1166. 5. Ruizhen Liu, Lu Gan*, Xiangliang, Huibi Xu. Chitosan as a condensing agent induces high gene transfection efficiency and low cytotoxicity of liposome. Journal of Bioscience and Bioengineering, 2011, 111(1): 98-103. 6. Bo Liu, Xiaohui Sun, Yanhong Zhu, Lu Gan*, Huibi Xu, Xiangliang Yang. Biphasic effects of H2O2 on BKCa channels. Free Radiccal Research, 2010, 44(9): 1004-1012. 7. Lu Gan, Ping Liu, Huarui Lu, Shuai Chen, Jianbo Yang, JB McCarthy, Karen E. Knudsen, Haojie Huang. Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis. Cell Death and Differentiation, 2009, 16 (10): 1408-1417. 8. Lu Gan, Shuai Chen, Yuwei Wang, Akira Watahiki, Laura Bohrer, Zhen Sun, Yuzhuo Wang, Haojie Huang. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer. Cancer Research, 2009, 69(21): 8386-8394. 9. Bo Liu, Lu Gan*, Xiaohui Sun, Yanhong Zhu, Zhihua Tong, Huibi Xu, Xiangliang Yang*. Biochimica et Biophysica Acta: Biomembranes, 2009, 1788 (10): 2174-2182. 10. Lu Gan, Xiangliang Yang, Qiong Liu, Huibi Xu. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells. Journal of Cellular Biochemistry, 2005, 96(3): 653-664. 11. Lu Gan, Shenghua Zhang, Xiangliang Yang, Huibi Xu. Immunomodulation and antitumor activity by a polysaccharide protein complex from Lycium barbarum. International Immunopharmacology, 2004, 4(4): 563-568. 12. Lu Gan, Shenghua Zhang, Qiong Liu, Huibi Xu. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. European Journal of Pharmacology, 2003, 471(3): 217-222. 13. Lu Gan, Qiong Liu, Huibi Xu, Yushan Zhu, Xiangliang Yang. Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biological Trace Element Research, 2002, 89(2):165-175. |